News | June 16, 2022
Enko advances Enkompass platform through DNA-encoded library technology
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Bayer now present in four of the largest biotechnology hubs in the United States
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The integration and transition of the brands are expected to be completed by June 2022.
Subscribe To Our Newsletter & Stay Updated
